Coulter Partners secures further nomination to Curetis N.V. Supervisory Board
10 May 2016 | By Coulter Partners
Coulter Partners was delighted to partner once again with German / Dutch diagnostics company Curetis N.V...
List view / Grid view
News
Expanding In Product Development for Logan Instruments Corp. with Balloon Stenting Instrumentation, Announcing ISO Certification and Upcoming Events
10 May 2016 | By Jensen Lee, Logan Instruments Corp
Logan Instruments Corp. has diversified its portfolio through the expanding use of their Disso III-7 instrument...
Positive Phase IIa study data for RPL554 in COPD
10 May 2016 | By Victoria White, Digital Content Producer
RPL554 is a novel inhaled dual PDE3/PDE4 inhibitor with both bronchodilator and anti-inflammatory properties in the same molecule...
Study identifies a safer treatment of acute stroke
10 May 2016 | By Victoria White, Digital Content Producer
Researchers have shown a modified dosage rtPA can reduce serious bleeding in the brain and improve survival rates in patients with acute stroke...
Takeda receives $38m grant to help eradicate polio
10 May 2016 | By Victoria White, Digital Content Producer
Takeda has received $38 million grant from the Bill & Melinda Gates Foundation to support global polio eradication in developing countries...
Bohle Blending Systems: An integral element to the L.B. Bohle success story for almost 30 years
9 May 2016 | By L.B. Bohle Maschinen + Verfahren GmbH
The company’s history began with a blender in 1987 – in the meantime, L.B. Bohle, the machine builder from Ennigerloh, has manufactured more than 3,000 blenders...
Incyte to acquire ARIAD’s European operations for $140m
9 May 2016 | By Victoria White, Digital Content Producer
The companies will also enter into a license agreement whereby Incyte will obtain an exclusive license to develop and commercialise Iclusig...
SMC says ‘no’ to Kalydeco and Orkambi in cystic fibrosis
The Scottish Medicines Consortium (SMC) has rejected Kalydeco (ivacaftor) and Orkambi (lumacaftor-ivacaftor) for the treatment of cystic fibrosis.
MGB Biopharma and FDA discuss MGB-BP-3 regulatory strategy
9 May 2016 | By Victoria White, Digital Content Producer
MGB Biopharma presented Phase I and preclinical data together with a proposal for the further development of oral MGB-BP-3 in C. difficile infections...
3BNC117 opens door to potential new treatment for HIV
Researchers are developing a new kind of treatment, an antibody-based drug called 3BNC117, that may provide a better strategy for long-term control of HIV...
Ulipristal acetate meets primary endpoints in uterine fibroid study
9 May 2016 | By Victoria White, Digital Content Producer
Allergan and Richter have announced positive results from Venus I, evaluating the efficacy and safety of ulipristal acetate in women with uterine fibroids...
Akili starts enrolment for trial of ADHD digital medicine treatment
6 May 2016 | By Victoria White, Digital Content Producer
Akili has started enrolment for its pivotal STARS-ADHD trial that will evaluate the safety and efficacy of the company’s proprietary platform, Project: EVO...
NICE recommends adalimumab for hidradenitis suppurativa
The National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s Humira (adalimumab) for the treatment of active moderate to severe hidradenitis suppurativa (HS) in adult patients with an inadequate response to conventional systemic HS therapy.
NICE recommends alirocumab and evolocumab in draft guidance
6 May 2016 | By Victoria White, Digital Content Producer
Alirocumab and evolocumab are recommended for adults with primary hypercholesterolaemia or mixed dyslipidaemia...
EC approves eribulin for the treatment of advanced liposarcoma
5 May 2016 | By Victoria White, Digital Content Producer
Eribulin is approved for those patients who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease...
